|
Plant Health Progress - Plant Health Reviews - 21 June
2000 Reproduced, with permission, from APSnet Features, 1998. The American
Phytopathological Society, St. Paul, MN, U.S.A. Transgenic Virus Resistant Papaya: New Hope
Papaya is a tropical fruit crop that is normally consumed
fresh and is valued as a health food because it's rich in vitamins C and A. In Hawaii,
small high quality papayas, called the Hawaiian solo type, are grown commercially for
export to the mainland United States and Japan. It is the state's second largest fruit
crop. However, papaya is severely damaged when infected by the papaya ringspot potyvirus
(PRSV), which is rapidly transmitted by a number of aphid species. In fact, PRSV causes
the most serious virus disease of papaya worldwide. The PRSV threat in Hawaii PRSV was discovered in Hawaii in the 1940s and virtually eliminated large papaya
production on Oahu island in the 1950s, causing the papaya industry to relocate to Puna
district on Hawaii island in the early 1960s (Fig. 2). The papaya industry thrived in Puna because
of ideal rainfall conditions, availability of land, and most importantly, because Puna was
free of PRSV. Even though PRSV was only 19 miles away from Puna, geographic isolation and
diligent surveillance and rouging efforts had kept the virus from Puna and, consequently,
95% of Hawaii's papaya was being produced in Puna by the 1980s.
Despite this apparent freedom of PRSV in Puna, it was reasonable to assume that Puna would
eventually become infected with the virus (Fig. 3). Thus, in the late 1980s we started a research
project to develop transgenic papaya by using the new concept of 'pathogen-derived
resistance', where it was proposed that transforming plants with a pathogen's gene would
result in the transgenic plant being resistant (Fig. 4). In other words, a gene from the pathogen
was being used to fight against the pathogen itself. Work progressed rapidly, primarily
because the team (Gonsalves, Slightom, Manshardt, and Fitch) had a focused approach and
had the right blend of expertise. Additionally, we had the good fortune to work with Dr.
John Sanford at Cornell University, Geneva, New York who had recently invented the gene
gun, a device that can literally "shoot" genetic information obtained from one
kind of organism into cells of another. A papaya transformation system was developed whereby young embryos from papaya seeds of the commercial Hawaiian solo cultivar 'Sunset' were
transformed with the coat protein gene of a PRSV isolate from Hawaii and a promising
transgenic papaya line (55-1) that showed resistance to PRSV from Hawaii was identified in
1991.
A transgenic line shows promise Two critical things happened in 1992. A small scale field trial of line 55-1 was initiated
on Oahu island in April and the long awaited invasion of PRSV into the Puna district was
observed in May. By December 1992, the results from the Oahu island field trial showed
that line 55-1 was highly resistant to PRSV (Fig. 5). While all control plants became infected in
77 days, R0 clones of line 55-1 remained resistant to PRSV.
Field evaluations of transgenic papaya In 1994, Dr. Steve Ferreira joined the team and directed the establishment of a large
scale field trial of transgenic papaya near an abandoned papaya orchard in
Puna, following
guidelines spelled out in a permit from the Animal Plant Health Inspection Service
(APHIS). The field trial consisted of the newly named 'UH SunUp', which is line 55-1 that
is homozygous for the coat protein gene, and 'UH Rainbow', which is a hybrid resulting
from a cross of 'UH SunUp' and nontransgenic 'Kapoho', the dominant papaya cultivar grown
in Hawaii. Like the first field trial, results were dramatic. All nontransgenic plants
became infected 11 months after transplanting while all but three of the transgenic plants
have remained resistant to PRSV even 35 months after initiating the trial. Fruit quality
of 'UH SunUp' and 'UH Rainbow' were good and farmers voiced approval of these transgenic
papaya.
Approval for commercialization of transgenics
However, could line 55-1 be deregulated and commercialized in time to help the papaya growers? Efforts to deregulate the papaya through APHIS and the Environmental Protection Agency (EPA) , and to hold consultations with the Food and Drug Administration (FDA) were initiated in 1995. By September 1997, these processes had been completed, with excellent cooperation from these agencies. The other phase of commercialization, obtaining
licenses from owners of intellectual property rights which were used to develop the
transgenic papaya, was undertaken in 1995 by the Papaya Administrative Committee (PAC), a
USDA marketing order group consisting of many of Hawaii papaya growers. Due to the
severity of the PRSV problem in Hawaii, PAC funded a program to produce seeds of 'UH
SunUp' and 'UH Rainbow' so that these would be available near the time that the papaya was
commercialized. All license agreements were completed by April 1998 and distributions of
transgenic papaya seeds to Hawaii papaya growers were started in May 1998. The future of transgenic papaya The impact of the transgenic papaya on reclaiming the papaya growing area in Puna will be
known in the next several years. We are hopeful that Hawaii papaya growers will find good
fortune at the end of the 'Rainbow.'
|
||||||||||||||||||||||||||||||||